Calm heads and clear information needed on nuclear medicine and waste claims

Normal.dotm 0 0 1 11 64 home 1 1 78 12.0 0 false 18 pt 18 pt 0 0 false false false /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US;}

Calm heads and clear information needed on nuclear medicine and waste claims

 

Monday 8th February 2016: Media reports linking continued access to nuclear medicine to the development of a new national nuclear waste facility do not correctly reflect the situation or advance considered discussion of these issues, according to leading national public health group the Medical Association for the Prevention of War (MAPW).

The Australian Nuclear Science and Technology Organisation (ANSTOi), which runs the Lucas Heights reactor, has increased pressure on the waste dump selection process by saying it will run out of storage capacity by early 2017, and will have to stop making medical isotopes for nuclear medicine use. This statement omits many facts.

ANSTOi has quietly decided to develop a reactor based export industry for medical isotopes, to supply 30% of the world market. This plan, made with no public debate or inquiry, would very significantly increase waste from reactor use. In contrast, Canada had an extensive public review of its reactor production in 2009, and decided it did not wish to continue using a reactor to produce isotopes. Reasons included lack of reliable supply (reactors only operate 80% of the year, and do break down from time to time), expense to the taxpayer of the production, and the burden of nuclear waste left in Canada due to international use.

The Canadians have developed proven methods of isotope production using cyclotrons (which does not generate reactor waste), with a successful pilot in January 2015. They are now in the process of scaling up and getting regulatory approvals for this, and look to be able to supply Canada in the next 3-5 years.

It should be noted that using medical isotope produces extremely little waste. It is reactor production of isotopes that needs public debate and scrutiny.

Australia has a choice – and the wider community needs a voice:

We can continue with ANSTO’s business plan, and export to supply the world market. This will leave Australia with vastly increased burden of nuclear waste from international nuclear medicine use, and is the more expensive option.

We can return to business as usual supplying Australia, which means we produce isotopes less than one day a week (not five days a week), with a subsequent major decrease in radioactive waste. This would enable all parties to plan world’s best practice storage in a rational and calm manner. We could further partner with Canada and work to develop cyclotron production of isotopes at commercial scale in Australia.

This is cheaper and more reliable than reactor production, and does not leave communities, taxpayers and future generations with a nuclear waste burden that will last for millennia. And unlike a nuclear reactor, it poses almost no accident, proliferation or terrorist risks. We do not need to choose between access to nuclear medicine and the time and processes needed to advance responsible radioactive waste management.

 For comment please contact Dr Margaret Beavis President 0401 99 56 99

Normal.dotm 0 0 1 432 2463 home 20 4 3024 12.0 0 false 18 pt 18 pt 0 0 false false false /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Cambria; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US;}